Abiopharma

Perfect Corp. Brings the Bleeding-Edge of AI Innovation to Viva Tech 2026

Change in holdings of interested parties/officers

Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma

Lehav announcement: M. understandings to acquire control in a renewable energy and storage platform in Europe, details

uCloudlink Triumphs at MVNOs World Awards 2026; Unveils Dual-Framework Solutions for Global Carrier Hyper-Growth USA - English USA - English APAC - English

Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma

Partial early redemption of TASE UP (Series 1) issued to institutional investors on 21.6.26

Extraordinary/ Special General Meeting:

Duos Edge AI to Host Dumas Edge Data Center Open House

Register of shareholders, changes and capital status – exercise of employee warrants and expiration of employee warrants of the company.